Ed oversees global financial performance at Variantyx. Prior to his work at Variantyx, Ed served as the Chief Financial Officer of 9Meters Biopharma (Nasdaq:NMTR), a clinical stage company developing therapeutic approaches that treat people with rare and debilitating conditions by leveraging the biology of the gut. Ed is an experienced financial executive with an extensive healthcare background. He has led both public and private companies, raising substantial capital and improving operations. He holds a B.S. in accounting from the University of Scranton and is licensed as a Certified Public Accountant in New Jersey.